BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de Ledinghen V, Francoz C, Sauvanet A, Vilgrain V, Belghiti J, Durand F, Valla D. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006;44:1308-1316. [PMID: 17058215 DOI: 10.1002/hep.21354] [Cited by in Crossref: 188] [Cited by in F6Publishing: 124] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Hoekstra J, Leebeek FW, Plessier A, Raffa S, Darwish Murad S, Heller J, Hadengue A, Chagneau C, Elias E, Primignani M. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study. J Hepatol. 2009;51:696-706. [PMID: 19664836 DOI: 10.1016/j.jhep.2009.06.019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
2 Pedersen MR, Molloy P, Wood D, Seetharam A. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome. Ann Hepatol 2016;15:127-30. [PMID: 26626649 DOI: 10.5604/16652681.1184288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Kathuria R, Srivastava A, Yachha SK, Poddar U, Baijal SS. Budd–Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome. European Journal of Gastroenterology & Hepatology 2014;26:1030-8. [DOI: 10.1097/meg.0000000000000144] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 4.1] [Reference Citation Analysis]
4 Zhang W, Wang QZ, Chen XW, Zhong HS, Zhang XT, Chen XD, Xu K. Budd-Chiari syndrome in China: A 30-year retrospective study on survival from a single center. World J Gastroenterol 2018; 24(10): 1134-1143 [PMID: 29563757 DOI: 10.3748/wjg.v24.i10.1134] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, Xu H, Mancuso A, Zhang W, Han X. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment Pharmacol Ther. 2016;44:1152-1167. [PMID: 27734511 DOI: 10.1111/apt.13815] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 8.2] [Reference Citation Analysis]
6 Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J. 2015;3:489-500. [PMID: 26668741 DOI: 10.1177/2050640615582293] [Cited by in Crossref: 47] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]
7 Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome. Radiology. 2017;283:280-292. [PMID: 27797679 DOI: 10.1148/radiol.2016152641] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
8 Han G, Qi X, Zhang W, He C, Yin Z, Wang J, Xia J, Xu K, Guo W, Niu J, Wu K, Fan D. Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology. 2013;266:657-667. [PMID: 23143028 DOI: 10.1148/radiol.12120856] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
9 Clark PJ, Slaughter RE, Radford DJ. Systemic thrombolysis for acute, severe Budd-Chiari syndrome. J Thromb Thrombolysis 2012;34:410-5. [DOI: 10.1007/s11239-012-0760-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
10 Qi XS, Ren WR, Fan DM, Han GH. Selection of treatment modalities for Budd-Chiari Syndrome in China: A preliminary survey of published literature. World J Gastroenterol 2014; 20(30): 10628-10636 [PMID: 25132785 DOI: 10.3748/wjg.v20.i30.10628] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
11 Shalimar, Kumar A, Kedia S, Sharma H, Gamanagatti SR, Gulati GS, Nayak B, Thakur B, Acharya SK. Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score. Aliment Pharmacol Ther 2016;43:1154-67. [PMID: 27060876 DOI: 10.1111/apt.13604] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
12 Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denié C, Chagneau-Derrode C, Charpignon C, Lédinghen Vd, Grenouillet-Delacre M, Habersetzer F, Nousbaum JB, Denninger MH, Valla DC, Plessier A. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol. 2009;104:1140-1146. [PMID: 19337247 DOI: 10.1038/ajg.2009.63] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
13 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
14 Zhang W, Tian YL, Wang QZ, Chen XW, Li QY, Han JH, Chen XD, Xu K. Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients. World J Clin Cases 2020; 8(14): 2930-2941 [PMID: 32775375 DOI: 10.12998/wjcc.v8.i14.2930] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center. Cardiovasc Intervent Radiol. 2014;37:691-697. [PMID: 23860938 DOI: 10.1007/s00270-013-0697-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
16 Parekh J, Matei VM, Canas-Coto A, Friedman D, Lee WM; Acute Liver Failure Study Group. Budd-chiari syndrome causing acute liver failure: A multicenter case series. Liver Transpl. 2017;23:135-142. [PMID: 27656864 DOI: 10.1002/lt.24643] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
17 Boozari B, Bahr MJ, Kubicka S, Klempnauer J, Manns MP, Gebel M. Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications. J Hepatol. 2008;49:572-580. [PMID: 18619699 DOI: 10.1016/j.jhep.2008.04.025] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
18 Wu M, Xu J, Shi D, Shen H, Wang M, Li Y, Han X, Zhai S. Evaluations of non-contrast enhanced MR venography with inflow inversion recovery sequence in diagnosing Budd–Chiari syndrome. Clinical Imaging 2014;38:627-32. [DOI: 10.1016/j.clinimag.2014.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
19 Desbois AC, Rautou PE, Biard L, Belmatoug N, Wechsler B, Resche-Rigon M, Zarrouk V, Fantin B, de Chambrun MP, Cacoub P, Valla D, Saadoun D, Plessier A. Behcet's disease in Budd-Chiari syndrome. Orphanet J Rare Dis 2014;9:104. [PMID: 25213625 DOI: 10.1186/s13023-014-0153-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 4.9] [Reference Citation Analysis]
20 Khan F, Armstrong MJ, Mehrzad H, Chen F, Neil D, Brown R, Cain O, Tripathi D. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther. 2019;49:840-863. [PMID: 30828850 DOI: 10.1111/apt.15149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
21 Mancuso A. Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist's Perspective. J Transl Int Med. 2017;5:194-199. [PMID: 29340275 DOI: 10.1515/jtim-2017-0033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
22 Qi X, He C, Han G, Yin Z, Wu F, Zhang Q, Niu J, Wu K, Fan D. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 2013;28:148-52. [PMID: 23020629 DOI: 10.1111/j.1440-1746.2012.07282.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
23 Fu Y, Sun Y, Ma X, Xu P, Feng L, Tang Z, Guan S, Wang Z, Luo C. Necessity and indications of invasive treatment for Budd-Chiari syndrome. Hepatobiliary & Pancreatic Diseases International 2011;10:254-60. [DOI: 10.1016/s1499-3872(11)60042-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
24 Garcia–pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Abraldes JG, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J. TIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients. Gastroenterology 2008;135:808-15. [DOI: 10.1053/j.gastro.2008.05.051] [Cited by in Crossref: 227] [Cited by in F6Publishing: 157] [Article Influence: 17.5] [Reference Citation Analysis]
25 Mancuso A, Martinelli L, De Carlis L, Rampoldi AG, Magenta G, Cannata A, Belli LS. A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction. World J Hepatol 2013; 5(5): 292-295 [PMID: 23717741 DOI: 10.4254/wjh.v5.i5.292] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
26 Zhou WJ, Cui YF, Zu MH, Zhang QQ, Xu H. Budd-Chiari Syndrome in Young Chinese: Clinical Characteristics, Etiology and Outcome of Recanalization from a Single Center. Cardiovasc Intervent Radiol 2016;39:557-65. [PMID: 26811088 DOI: 10.1007/s00270-016-1295-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Riggio O, Marzano C, Papa A, Pasquale C, Gasperini ML, Gigante A, Valla DC, Plessier A, Amoroso A. Small hepatic veins Budd-Chiari syndrome. J Thromb Thrombolysis 2014;37:536-9. [PMID: 23813023 DOI: 10.1007/s11239-013-0959-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Orloff MJ, Isenberg JI, Wheeler HO, Daily PO, Girard B. Budd–Chiari Syndrome Revisited: 38 Years’ Experience with Surgical Portal Decompression. J Gastrointest Surg 2012;16:286-300. [DOI: 10.1007/s11605-011-1738-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
29 Marongiu F, Tosetto A, Palareti G. Special indications for vitamin K antagonists: a review. Intern Emerg Med 2012;7:21-5. [PMID: 21380552 DOI: 10.1007/s11739-011-0543-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-vallée J, Duvoux C, Lerut J, Le Treut Y, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F. Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score-based liver allocation system: Meld Exceptions in the French System. Liver Transpl 2011;17:1137-51. [DOI: 10.1002/lt.22363] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
31 MacNicholas R, Olliff S, Elias E, Tripathi D. An update on the diagnosis and management of Budd-Chiari syndrome. Expert Rev Gastroenterol Hepatol. 2012;6:731-744. [PMID: 23237258 DOI: 10.1586/egh.12.56] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
32 Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48 Suppl 1:S68-S92. [PMID: 18304681 DOI: 10.1016/j.jhep.2008.01.021] [Cited by in Crossref: 190] [Cited by in F6Publishing: 154] [Article Influence: 14.6] [Reference Citation Analysis]
33 Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson Å, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver International 2009;29:253-9. [DOI: 10.1111/j.1478-3231.2008.01838.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 67] [Article Influence: 7.2] [Reference Citation Analysis]
34 Brodsky A, Mazzocchi O, Sánchez F, Khursigara G, Malhotra S, Volpacchio M. Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation. Exp Hematol Oncol 2012;1:26. [PMID: 23210433 DOI: 10.1186/2162-3619-1-26] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
35 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol. 2014;31:235-242. [PMID: 25177083 DOI: 10.1055/s-0034-1382790] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 6.9] [Reference Citation Analysis]
36 Coilly A, Potier P, Broué P, Kounis I, Valla D, Hillaire S, Lambert V, Dutheil D, Hernández-gea V, Plessier A, Vilgrain V, Bureau C. Budd-Chiari syndrome. Clinics and Research in Hepatology and Gastroenterology 2020;44:420-5. [DOI: 10.1016/j.clinre.2020.03.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
37 Bechmann LP, Sichau M, Wichert M, Gerken G, Kröger K, Hilgard P. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int. 2011;31:75-82. [PMID: 20958919 DOI: 10.1111/j.1478-3231.2010.02358.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 8.0] [Reference Citation Analysis]
38 Mancuso A. The ischemic liver cirrhosis theory and its clinical implications. Med Hypotheses 2016;94:4-6. [PMID: 27515188 DOI: 10.1016/j.mehy.2016.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
39 Zahn A, Gotthardt D, Weiss KH, Richter G, Schmidt J, Stremmel W, Sauer P. Budd-Chiari syndrome: long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt. BMC Gastroenterol. 2010;10:25. [PMID: 20193077 DOI: 10.1186/1471-230x-10-25] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
40 Westbrook RH, Lea NC, Mohamedali AM, Smith AE, Orr DW, Roberts LN, Heaton ND, Wendon JA, O’Grady JG, Heneghan MA. Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation. Liver Transpl. 2012;18:819-827. [PMID: 22467227 DOI: 10.1002/lt.23443] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
41 Strauss E, Valla D. Non-cirrhotic portal hypertension--concept, diagnosis and clinical management. Clin Res Hepatol Gastroenterol 2014;38:564-9. [PMID: 24581591 DOI: 10.1016/j.clinre.2013.12.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
42 Qi X, Fan D, Han G. Timing of transjugular intrahepatic portosystmic for Budd-Chiari syndrome: still an open issue. Liver Int 2014;34:1288-9. [PMID: 24684318 DOI: 10.1111/liv.12554] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Ren K, Xu K, Sun W, Chen Y, Qi X, Li R, Jin A. Preliminary evaluation of magnetic resonance fresh blood imaging for diagnosis of Budd-Chiari syndrome: . Chinese Medical Journal 2007;120:95-9. [DOI: 10.1097/00029330-200701020-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
44 Sun Y, Fu Y, Zhou L, Ma X, Wang Z, Wu Y. Staged management of Budd-Chiari syndrome caused by co-obstruction of the inferior vena cava and main hepatic veins. Hepatobiliary & Pancreatic Diseases International 2013;12:278-85. [DOI: 10.1016/s1499-3872(13)60045-4] [Cited by in Crossref: 9] [Article Influence: 1.1] [Reference Citation Analysis]
45 Cheng D, Xu H, Lu Z, Hua R, Qiu H, Du H, Xu X, Zhang J. Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: A single-center study: Budd-Chiari syndrome in Chinese patients. J Gastroenterol Hepatol 2013;28:1061-7. [DOI: 10.1111/jgh.12140] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
46 Sabol TP, Molina M, Wu GY. Thrombotic Venous Diseases of the Liver. J Clin Transl Hepatol 2015;3:189-94. [PMID: 26623265 DOI: 10.14218/JCTH.2015.00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Horton JD, San Miguel FL, Membreno F, Wright F, Paima J, Foster P, Ortiz JA. Budd-Chiari syndrome: illustrated review of current management. Liver Int. 2008;28:455-466. [PMID: 18339072 DOI: 10.1111/j.1478-3231.2008.01684.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
48 Riggio O, Ridola L, Lucidi C, Angeloni S. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig Liver Dis. 2010;42:462-467. [PMID: 20036625 DOI: 10.1016/j.dld.2009.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
49 Ishikawa M, Sakamoto A. Open Cardiac Surgery in a Patient With Chronic Budd-Chiari Syndrome. J Cardiothorac Vasc Anesth 2021;35:3042-4. [PMID: 33358289 DOI: 10.1053/j.jvca.2020.11.063] [Reference Citation Analysis]
50 Kaneko J, Sugawara Y, Tamura S, Togashi J, Matsui Y, Makuuchi M. Heparin-induced thrombocytopenia after liver transplantation. Transplant Proc. 2008;40:1518-1521. [PMID: 18589141 DOI: 10.1016/j.transproceed.2008.01.069] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
51 Plessier A. Syndrome de Budd-Chiari. La Revue de Médecine Interne 2013;34:741-5. [DOI: 10.1016/j.revmed.2013.02.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Salmela B, Nordin A, Vuoristo M, Mäkisalo H, Numminen K, Lassila R. Budd–Chiari syndrome in a young female with factor V Leiden mutation: Successful treatment with lepirudin, a direct thrombin inhibitor. Thrombosis Research 2008;121:769-72. [DOI: 10.1016/j.thromres.2007.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Segev DL, Nguyen GC, Locke JE, Simpkins CE, Montgomery RA, Maley WR, Thuluvath PJ. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl. 2007;13:1285-1294. [PMID: 17763380 DOI: 10.1002/lt.21220] [Cited by in Crossref: 78] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
54 Beckett D, Olliff S. Interventional radiology in the management of Budd Chiari syndrome. Cardiovasc Intervent Radiol. 2008;31:839-847. [PMID: 18214592 DOI: 10.1007/s00270-007-9285-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
55 Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH. Budd-Chiari syndrome associated with Behçet’s disease. Gastroenterol Clin Biol. 2008;32:316-320. [PMID: 18400436 DOI: 10.1016/j.gcb.2007.12.022] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
56 Ding PX, Han XW, Liu C, Zhang Y, Cheng AL, Wu Y, Liang XX, Gao XM, Lee EW. Long-term outcomes of individualized treatment strategy in treatment of type I Budd-Chiari syndrome in 456 patients. Liver Int. 2019;39:1577-1586. [PMID: 30963702 DOI: 10.1111/liv.14114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
57 Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant. HPB (Oxford). 2014;16:481-493. [PMID: 23961811 DOI: 10.1111/hpb.12163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
58 Fan X, Liu K, Che Y, Wang S, Wu X, Cao J, Li J. Good Clinical Outcomes in Budd-Chiari Syndrome with Hepatic Vein Occlusion. Dig Dis Sci. 2016;61:3054-3060. [PMID: 27221497 DOI: 10.1007/s10620-016-4208-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
59 Inchingolo R, Posa A, Mariappan M, Tibana TK, Nunes TF, Spiliopoulos S, Brountzos E. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review. World J Gastroenterol 2020; 26(34): 5060-5073 [PMID: 32982109 DOI: 10.3748/wjg.v26.i34.5060] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Di Nisio M, Valeriani E, Riva N, Schulman S, Beyer-Westendorf J, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost 2020;18:1562-8. [PMID: 32619346 DOI: 10.1111/jth.14836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
61 Zaman S, Wiebe S, Bernal W, Wendon J, Czuprynska J, Auzinger G. Increased prevalence of heparin-induced thrombocytopenia in patients with Budd-Chiari syndrome: a retrospective analysis. Eur J Gastroenterol Hepatol. 2016;28:967-971. [PMID: 27015137 DOI: 10.1097/meg.0000000000000632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
62 Ollivier-hourmand I, Allaire M, Goutte N, Morello R, Chagneau-derrode C, Goria O, Dumortier J, Cervoni JP, Dharancy S, Ganne-carrié N, Bureau C, Carbonell N, Abergel A, Nousbaum JB, Anty R, Barraud H, Ripault MP, De Ledinghen V, Minello A, Oberti F, Radenne S, Bendersky N, Farges O, Archambeaud I, Guillygomarc’h A, Ecochard M, Ozenne V, Hilleret MN, Nguyen-khac E, Dauvois B, Perarnau JM, Lefilliatre P, Raabe JJ, Doffoel M, Becquart JP, Saillard E, Valla D, Dao T, Plessier A. The epidemiology of Budd–Chiari syndrome in France. Digestive and Liver Disease 2018;50:931-7. [DOI: 10.1016/j.dld.2018.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
63 Naymagon L. Venous thrombosis of the liver: current and emerging concepts in management. Transl Res 2020;225:54-69. [PMID: 32407789 DOI: 10.1016/j.trsl.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
64 Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol. 2015;9:865-875. [PMID: 25754880 DOI: 10.1586/17474124.2015.1024224] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
65 Chayanupatkul M, Rhee JH, Kumar AR, Varadi G. Tamoxifen-associated Budd-Chiari syndrome complicated by heparin-induced thrombocytopenia and thrombosis: a case report and literature review. BMJ Case Rep 2012;2012:bcr2012007411. [PMID: 23213131 DOI: 10.1136/bcr-2012-007411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Shukla A, Bhatia SJ. Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone. Indian J Gastroenterol 2010;29:14-7. [DOI: 10.1007/s12664-010-8002-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
67 Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC;  European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013;57:1962-1968. [PMID: 23389867 DOI: 10.1002/hep.26306] [Cited by in Crossref: 174] [Cited by in F6Publishing: 114] [Article Influence: 21.8] [Reference Citation Analysis]
68 Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int. 2018;12:168-180. [PMID: 28685257 DOI: 10.1007/s12072-017-9810-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
69 Qi XS, Bai M, Yang ZP, Fan DM. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: An evidence-based review. World J Gastroenterol 2014; 20(21): 6470-6480 [PMID: 24914368 DOI: 10.3748/wjg.v20.i21.6470] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
70 Murad SD, Kamath PS. Liver transplantation for Budd-Chiari syndrome: When is it really necessary? Liver Transpl 2008;14:133-5. [DOI: 10.1002/lt.21286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
71 Mancuso A. Budd-chiari syndrome management: Timing of treatment is an open issue. Hepatology 2014;59:1213. [PMID: 23857382 DOI: 10.1002/hep.26619] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
72 Neumann AB, Andersen SD, Nielsen DT, Holland-Fischer P, Vilstrup H, Grønbæk H. Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt. World J Hepatol 2013; 5(1): 38-42 [PMID: 23383365 DOI: 10.4254/wjh.v5.i1.38] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
73 Rautou PE, Moucari R, Cazals-Hatem D, Escolano S, Denié C, Douarin L, Francoz C, Durand F, Ozenne V, Imbert A, Moreau R, Lebrec D, Plessier A, Valla D. Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome. Clin Gastroenterol Hepatol 2009;7:1230-5. [PMID: 19560555 DOI: 10.1016/j.cgh.2009.06.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
74 Bernuau J, Durand F. Early prediction of encephalopathy in hospitalized patients with severe acute liver disease: The narrow window of opportunity for transplant-free survival. Journal of Hepatology 2009;51:977-80. [DOI: 10.1016/j.jhep.2009.09.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
75 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179-202. [PMID: 26516032 DOI: 10.1016/j.jhep.2015.07.040] [Cited by in Crossref: 291] [Cited by in F6Publishing: 197] [Article Influence: 48.5] [Reference Citation Analysis]
76 Shukla A, Sadalage A, Gupta D, Gupte A, Mahapatra A, Mazumder D, Shah C, Modi T, Meshram M, Dhore P, Bhatia S. Pregnancy outcomes in women with Budd Chiari Syndrome before onset of symptoms and after treatment. Liver Int 2018;38:754-9. [PMID: 28834123 DOI: 10.1111/liv.13552] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
77 Campbell RAS, Thomson EM, Beattie C. Effect of Liver Disease Etiology on ROTEM Profiles in Patients Undergoing Liver Transplantation. Transplant Proc 2019;51:783-9. [PMID: 30979465 DOI: 10.1016/j.transproceed.2018.12.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-38. [PMID: 22300463 DOI: 10.1016/S0168-8278(12)60004-X] [Cited by in Crossref: 132] [Cited by in F6Publishing: 38] [Article Influence: 14.7] [Reference Citation Analysis]
79 Rautou PE, Angermayr B, Garcia-Pagan JC, Moucari R, Peck-Radosavljevic M, Raffa S, Bernuau J, Condat B, Levardon M, Yver C. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol. 2009;51:47-54. [PMID: 19443069 DOI: 10.1016/j.jhep.2009.02.028] [Cited by in Crossref: 58] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
80 Mo A, Testro A, French J, Robertson M, Angus P, Grigg A. Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome. Intern Med J. 2017;47:1361-1367. [PMID: 28675622 DOI: 10.1111/imj.13544] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
81 Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64:933-945. [PMID: 26658682 DOI: 10.1016/j.jhep.2015.11.030] [Cited by in Crossref: 92] [Cited by in F6Publishing: 53] [Article Influence: 15.3] [Reference Citation Analysis]
82 Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol 2019;71:175-99. [PMID: 30822449 DOI: 10.1016/j.jhep.2019.02.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 15.5] [Reference Citation Analysis]
83 Akamatsu N, Sugawara Y, Kokudo N. Budd-Chiari syndrome and liver transplantation. Intractable Rare Dis Res. 2015;4:24-32. [PMID: 25674385 DOI: 10.5582/irdr.2014.01031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
84 Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, Deshmukh H, Cua IHY, Lesmana CRA, Al Meshtab M, Kage M, Chaiteeraki R, Treeprasertsuk S, Giri S, Punamiya S, Paradis V, Qi X, Sugawara Y, Abbas Z, Sarin SK. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021;15:531-67. [PMID: 34240318 DOI: 10.1007/s12072-021-10189-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Li T, Zhai S, Pang Z, Ma X, Cao H, Bai W, Wang Z, Zhang WW. Feasibility and midterm outcomes of percutaneous transhepatic balloon angioplasty for symptomatic Budd-Chiari syndrome secondary to hepatic venous obstruction. J Vasc Surg 2009;50:1079-84. [PMID: 19703746 DOI: 10.1016/j.jvs.2009.06.049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
86 Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. Am J Gastroenterol. 2020;115:18-40. [PMID: 31895720 DOI: 10.14309/ajg.0000000000000486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 26.0] [Reference Citation Analysis]
87 Li T, Zhang WW, Bai W, Zhai S, Pang Z. Warfarin anticoagulation before angioplasty relieves thrombus burden in Budd-Chiari syndrome caused by inferior vena cava anatomic obstruction. J Vasc Surg 2010;52:1242-5. [PMID: 20674242 DOI: 10.1016/j.jvs.2010.05.098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
88 Mancuso A. Controversies in the Management of Budd–Chiari Syndrome. In: Qi X, editor. Budd-Chiari Syndrome. Singapore: Springer; 2020. pp. 245-52. [DOI: 10.1007/978-981-32-9232-1_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Hermeziu B, Franchi-Abella S, Plessier A, Habes D, Mosca A, Sibert A, Bernard O, Pariente D, Jacquemin E. Budd-Chiari syndrome and essential thrombocythemia in a child: favorable outcome after transjugular intrahepatic portosystemic shunt. J Pediatr Gastroenterol Nutr 2008;46:334-7. [PMID: 18376254 DOI: 10.1097/MPG.0b013e31814d4e0a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
90 Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Darwish Murad S. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 2008;111:4922-4929. [PMID: 18250227 DOI: 10.1182/blood-2007-11-125328] [Cited by in Crossref: 226] [Cited by in F6Publishing: 176] [Article Influence: 17.4] [Reference Citation Analysis]
91 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 28.0] [Reference Citation Analysis]
92 Goel RM, Johnston EL, Patel KV, Wong T. Budd-Chiari syndrome: investigation, treatment and outcomes. Postgrad Med J 2015;91:692-7. [PMID: 26494427 DOI: 10.1136/postgradmedj-2015-133402] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
93 Senzolo M, Riggio O, Primignani M; Italian Association for the Study of the Liver (AISF) ad hoc. Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. Dig Liver Dis. 2011;43:503-514. [PMID: 21185794 DOI: 10.1016/j.dld.2010.11.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
94 Plessier A, Valla D. Syndrome de Budd-Chiari. EMC - Hépatologie 2006;1:1-9. [DOI: 10.1016/s1155-1976(06)41408-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008;47:1384-93. [DOI: 10.1002/hep.22192] [Cited by in Crossref: 77] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
96 Walldorf J, Tannapfel A, Holzhausen HJ, Wittekind C, Seufferlein T, Settmacher U, Fleig WE, Dollinger MM. Rapid development of a hepatocellular carcinoma in isolated thrombosis of hepatic veins (classic Budd-Chiari syndrome): case report and review of literature. BMJ Case Rep 2009;2009:bcr07. [PMID: 22125582 DOI: 10.1136/bcr.07.2009.2057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol. 2013;48:771-784. [PMID: 23506234 DOI: 10.3109/00365521.2013.777775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
98 Aggarwal N, Suri V, Chopra S, Sikka P, Dhiman RK, Chawla YK. Pregnancy outcome in Budd Chiari Syndrome-a tertiary care centre experience. Arch Gynecol Obstet 2013;288:949-52. [DOI: 10.1007/s00404-013-2834-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
99 Das CJ, Soneja M, Tayal S, Chahal A, Srivastava S, Kumar A, Baruah U. Role of radiological imaging and interventions in management of Budd-Chiari syndrome. Clin Radiol 2018;73:610-24. [PMID: 29549997 DOI: 10.1016/j.crad.2018.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
100 Desbois AC, Plessier A. Why and when to diagnose Behcet's disease in patients with Budd Chiari Syndrome? Clin Res Hepatol Gastroenterol 2020;44:385-6. [PMID: 31917175 DOI: 10.1016/j.clinre.2019.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Copelan A, Remer EM, Sands M, Nghiem H, Kapoor B. Diagnosis and management of Budd Chiari syndrome: an update. Cardiovasc Intervent Radiol. 2015;38:1-12. [PMID: 24923240 DOI: 10.1007/s00270-014-0919-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
102 Seijo S, Garcia-pagan JC. An overview of current treatment methods for Budd–Chiari syndrome. Expert Opinion on Orphan Drugs 2014;2:147-57. [DOI: 10.1517/21678707.2014.872560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Rautou PE, Douarin L, Denninger MH, Escolano S, Lebrec D, Moreau R, Vidaud M, Itzykson R, Moucari R, Bezeaud A. Bleeding in patients with Budd-Chiari syndrome. J Hepatol. 2011;54:56-63. [PMID: 20889223 DOI: 10.1016/j.jhep.2010.06.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
104 Elsayes KM, Shaaban AM, Rothan SM, Javadi S, Madrazo BL, Castillo RP, Casillas VJ, Menias CO. A Comprehensive Approach to Hepatic Vascular Disease. RadioGraphics 2017;37:813-36. [DOI: 10.1148/rg.2017160161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
105 Ulrich F, Pratschke J, Neumann U, Pascher A, Puhl G, Fellmer P, Weiss S, Jonas S, Neuhaus P. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl 2008;14:144-50. [PMID: 18236386 DOI: 10.1002/lt.21282] [Cited by in Crossref: 59] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
106 Mancuso A. An update on management of Budd-Chiari syndrome. Annals of Hepatology 2014;13:323-6. [DOI: 10.1016/s1665-2681(19)30860-9] [Cited by in Crossref: 26] [Article Influence: 3.7] [Reference Citation Analysis]
107 Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50:195-203. [PMID: 19012988 DOI: 10.1016/j.jhep.2008.10.007] [Cited by in Crossref: 214] [Cited by in F6Publishing: 140] [Article Influence: 16.5] [Reference Citation Analysis]
108 Hatzidakis A, Galanakis N, Kehagias E, Samonakis D, Koulentaki M, Matrella E, Tsetis D. Ultrasound-guided direct intrahepatic portosystemic shunt in patients with Budd-Chiari syndrome: Short- and long-term results. Interv Med Appl Sci 2017;9:86-93. [PMID: 28932502 DOI: 10.1556/1646.9.2017.2.14] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Khan F, Mehrzad H, Tripathi D. Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective. J Transl Int Med. 2018;6:97-104. [PMID: 30425945 DOI: 10.2478/jtim-2018-0022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
110 Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol. 2017;29:1174-1182. [PMID: 28763339 DOI: 10.1097/meg.0000000000000945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
111 Mancuso A. An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment. Eur J Gastroenterol Hepatol 2015;27:200-3. [PMID: 25590783 DOI: 10.1097/MEG.0000000000000282] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
112 De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern. Emerg Med. 2010;5:487-494. [PMID: 20532730 DOI: 10.1007/s11739-010-0413-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 7.2] [Reference Citation Analysis]
113 Hernández-Gea V, Bureau C. Practice makes better: TIPS procedures in referral centers. Hepatology 2018;67:473-5. [PMID: 28873237 DOI: 10.1002/hep.29507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Rathod K, Deshmukh H, Shukla A, Popat B, Pandey A, Gupte A, Gupta DK, Bhatia SJ. Endovascular treatment of Budd-Chiari syndrome: Single center experience. J Gastroenterol Hepatol. 2017;32:237-243. [PMID: 27218672 DOI: 10.1111/jgh.13456] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
115 DeLeve LD, Valla DC, Garcia-Tsao G;  American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764. [PMID: 19399912 DOI: 10.1002/hep.22772] [Cited by in Crossref: 599] [Cited by in F6Publishing: 426] [Article Influence: 49.9] [Reference Citation Analysis]
116 Chaudhuri M, Jayaranganath M, Chandra VS. Percutaneous Recanalization of an Occluded Hepatic Vein in a Difficult Subset of Pediatric Budd-Chiari Syndrome. Pediatr Cardiol 2012;33:806-10. [DOI: 10.1007/s00246-012-0188-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
117 Llop E, Seijo S. [Treatment of non-cirrhotic, non-tumoural portal vein thrombosis]. Gastroenterol Hepatol 2016;39:403-10. [PMID: 26547613 DOI: 10.1016/j.gastrohep.2015.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Bezinover D, Dirkmann D, Findlay J, Guta C, Hartmann M, Nicolau-raducu R, Mukhtar AM, Moguilevitch M, Pivalizza E, Rosenfeld D, Saner F, Wray C, Wagener G, West J. Perioperative Coagulation Management in Liver Transplant Recipients. Transplantation 2018;102:578-92. [DOI: 10.1097/tp.0000000000002092] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 10.3] [Reference Citation Analysis]
119 Chinnakotla S, Klintmalm GB, Kim P, Tomiyama K, Klintmalm E, Davis GL, Trotter JF, Saad R, Landaverde C, Levy MF, Goldstein RM, Stone MJ. Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology. Transplantation. 2011;92:341-345. [PMID: 21659946 DOI: 10.1097/tp.0b013e3182247b05] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
120 Plompen EP, Schouten JN, Janssen HL. Role of anticoagulant therapy in liver disease. Hepatol Int. 2013;7:369-376. [PMID: 26201771 DOI: 10.1007/s12072-013-9427-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
121 Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, Bai M, Niu J, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int. 2014;34:1164-1175. [PMID: 24256572 DOI: 10.1111/liv.12355] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
122 Gao X, Gui E, Lu Z, Ning X, Zu M, Zhang P, Sun G. Risk factors of recurrence among 471 Chinese patients with Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2015;39:620-626. [PMID: 25656980 DOI: 10.1016/j.clinre.2014.12.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
123 Zhang B, Jiang Z, Huang M, Zhu K, Qian J, Shan H. Effects of percutaneous transhepatic interventional treatment for symptomatic Budd-Chiari syndrome secondary to hepatic venous obstruction. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2013;1:392-9. [DOI: 10.1016/j.jvsv.2013.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
124 Mancuso A. Budd-Chiari syndrome management: Lights and shadows. World J Hepatology 2011; 3(10): 262-264 [PMID: 22059108 DOI: 10.4254/wjh.v3.i10.262] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]